The Gut-Endometriosis Axis: Genetic Mechanisms and Public Health Implications
- PMID: 40869964
- PMCID: PMC12385947
- DOI: 10.3390/genes16080918
The Gut-Endometriosis Axis: Genetic Mechanisms and Public Health Implications
Abstract
Background/Objectives: Endometriosis is a chronic, estrogen-driven gynecological disorder affecting approximately 10% of reproductive-aged women worldwide, with significant physical, psychosocial, and socioeconomic impacts. Recent research suggests a possible involvement of the gut microbiome in endometriosis disease mechanisms through immune manipulation, estrogen metabolism, and inflammatory networks. This narrative review aims to summarize current evidence on gut microbiota changes in endometriosis patients, explore the mechanisms by which gut dysbiosis contributes to disease progression, and examine epidemiological links between gastrointestinal health and endometriosis risk. Methods: A narrative review was conducted to synthesize available literature on the compositional changes in gut microbiota associated with endometriosis. The review also evaluated studies investigating potential mechanisms and epidemiological patterns connecting gut health with endometriosis development and severity. Results: Alterations in gut microbiota composition were observed in endometriosis patients, suggesting roles in immune dysregulation, estrogen metabolism, and inflammation. Potential gut-oriented interventions, including dietary changes, probiotics, and lifestyle modifications, emerged as promising management options. However, methodological variability and research gaps remain barriers to clinical translation. Conclusions: Integrating gut microbiome research into endometriosis management holds potential for improving early diagnosis, patient outcomes, and healthcare system sustainability. The study emphasizes the need for further research to address existing challenges and to develop public health strategies that incorporate microbiome-based interventions in population-level endometriosis care.
Keywords: dysbiosis; estrogen metabolism; gut microbiota; gut–endometriosis axis; inflammation; women’s health.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


References
-
- Tsamantioti E.S., Mahdy H. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2025. [(accessed on 7 July 2025)]. Endometriosis. Available online: http://www.ncbi.nlm.nih.gov/books/NBK567777/ - PubMed
-
- Cano-Herrera G., Salmun Nehmad S., Ruiz de Chávez Gascón J., Méndez Vionet A., van Tienhoven X.A., Osorio Martínez M.F., Muleiro Alvarez M., Vasco Rivero M.X., López Torres M.F., Barroso Valverde M.J., et al. Endometriosis: A Comprehensive Analysis of the Pathophysiology, Treatment, and Nutritional Aspects, and Its Repercussions on the Quality of Life of Patients. Biomedicines. 2024;12:1476. doi: 10.3390/biomedicines12071476. - DOI - PMC - PubMed
-
- Fryer J., Mason-Jones A.J., Woodward A. Understanding Diagnostic Delay for Endometriosis: A Scoping Review. Cold Spring Harbor Laboratory; Laurel Hollow, NY, USA: 2024. [(accessed on 7 July 2025)]. Available online: http://medrxiv.org/lookup/doi/10.1101/2024.01.08.24300988. - DOI
-
- Denny E., Weckesser A., Jones G., Bibila S., Daniels J., Bhattacharya S., PRE-EMPT team Women’s experiences of medical treatment for endometriosis and its impact on PRE-EMPT trial participation: A qualitative study. Pilot Feasibility Stud. 2018;4:168. doi: 10.1186/s40814-018-0358-5. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical